Sari Fishman
Corporate Officer/Principal bei CAN-FITE BIOPHARMA LTD.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Sari Fishman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | 01.01.2014 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.01.2014 |
Karriereverlauf von Sari Fishman
Ehemalige bekannte Positionen von Sari Fishman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Sari Fishman
| Bar-Ilan University | Doctorate Degree |
Statistik
International
| Israel | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
- Börse
- Insiders
- Sari Fishman
- Erfahrung
